Clinical studies have shown that HMGB1 and its associated inflammatory cytokines (IL-6, TNF-α) may be involved in the pathophysiological processes of dilated cardiomyopathy and accelerated heart function decline (Wu et al., 2013). The gene discussed is HMGB1; the disease is dilated cardiomyopathy.